The Influence of Maternal Cell Contamination on Fetal Aneuploidy Detection Using Chip-Based Digital PCR Testing

Anna Nykel1, Rafał Woźniak2, Agnieszka Gach2

  • 1Department of Genetics, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.

Insights

Chip-based digital PCR accurately detects fetal aneuploidies, even with high maternal cell contamination (MCC). This method simplifies prenatal testing by eliminating the need for additional MCC assays, reducing costs and improving efficiency.

Area of Science:

  • Molecular Biology
  • Genetics
  • Prenatal Diagnostics

Background:

  • Prenatal samples from amniocentesis or CVS risk maternal cell contamination (MCC).
  • High MCC levels can lead to failed prenatal analysis reports.
  • Traditional MCC detection methods are often complex and require additional testing.

Purpose of the Study:

  • To evaluate chip-based digital PCR for detecting fetal aneuploidies in samples with MCC.
  • To assess the accuracy of digital PCR in identifying specific aneuploidies (trisomy 21, 18, X monosomy) and Y chromosome presence under varying MCC levels.

Main Methods:

  • Serial dilution of aneuploid male samples with euploid female samples to simulate MCC.
  • DNA extraction from prenatal samples.
  • Analysis using QuantStudio 3D Digital PCR for aneuploidy detection and MCC quantification.

Main Results:

  • Accurate detection of trisomy 21, 18, and X monosomy with up to 90%, 85%, and 92% MCC, respectively.
  • Accurate confirmation of Y chromosome presence with up to 95% MCC.
  • Identification of 10 contaminated samples and four cases of true fetal mosaicism in clinical samples.

Conclusions:

  • Chip-based digital PCR reliably detects fetal aneuploidies even with significant maternal cell contamination.
  • The developed algorithm simplifies prenatal diagnostics by removing the need for separate maternal DNA testing and MCC assays.
  • This method offers a cost-effective, efficient, and clinically applicable approach for routine prenatal testing.